CEO, Atmo Biosciences
Stories naming Mal Hebblewhite. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Atmo Biosciences has won American regulator clearance for its swallowable gas-sensing capsule, an RMIT invention licensed in 2018; sales begin in July, after RMIT swapped the patents for equity in April.
Breakthrough Victoria bought shares in Atmo Biosciences from Planet Innovation, size undisclosed; the article also recalls Atmo's February 2023 Series B and Breakthrough Victoria's earlier investments in three manufacturers.